AXT, Inc. AXTI has the financial strength to support aggressive indium phosphide (InP) capacity expansion, positioning the company to capitalize on strong AI data-center demand.
AXT ended the second quarter with $748.8 million in cash, cash equivalents and investments, up $625.6 million sequentially, primarily following its April secondary offering, which generated approximately $632 million before expenses. This strengthened liquidity provides financial flexibility to expand its manufacturing footprint.
The timing is favorable because InP demand continues to exceed supply. AXT has committed to doubling InP capacity in 2026 and is ahead of schedule while planning another expansion in 2027. Its InP backlog has surpassed $100 million, providing visibility into future demand.
Customer commitments further strengthen the outlook. Long-term agreements with Casela and Coherent include wafer commitments and prepayments, while AXT’s Lumentum agreement reserves InP capacity through 2031.
Importantly, AXT’s second-quarter revenues reached a record $47.6 million, while GAAP gross margin climbed to 44.9%. The Zacks Consensus Estimate projects 2026 and 2027 revenue growth of 146.4% and 108.4%, respectively. Thus, strong liquidity and planned InP expansion provide a solid foundation for continued growth.
InP Capacity Race Raises Competitive Pressure on AXT
Coherent COHR is challenging AXTI by rapidly expanding its own InP production. COHR plans to double internal InP output year over year and more than double it again by the end of 2027. As COHR increases 6-inch production for EMLs, CW lasers and photodiodes, COHR’s vertical integration could reduce reliance on suppliers such as AXTI, intensifying competition.
Lumentum LITE is expanding internal InP wafer capacity across two Japanese fabs while converting its Greensboro facility from gallium arsenide to InP. The company also secured additional substrate supply from AXTI because demand surged. Lumentum is both a customer and a competitor of AXTI. As LITE ramps up its own InP production, it may need to source fewer products from AXTI.
AXTI’s Share Price Performance, Valuation & Estimates
AXTI shares have skyrocketed 325.4% year to date, significantly outperforming the broader Zacks Computer and Technology sector, which has gained 18.2%.
AXTI’s YTD Price Performance
Image Source: Zacks Investment Research
AXTI appears expensive at current valuations, with a forward P/S ratio of 11.99X, well above the Electronics – Semiconductors industry average of 4.94X. The company carries a Value Score of F.
AXTI’s Valuation
Image Source: Zacks Investment Research
AXTI is expected to deliver substantial earnings growth in the coming years. The Zacks Consensus Estimate projects 2026 earnings of 86 cents per share and 2027 earnings of $2.20; both estimates remain unchanged over the past 30-day period. These projections represent year-over-year growth of 309.8% and 155.8%, respectively.
Image Source: Zacks Investment Research
AXT stock currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AXT Inc (AXTI): Free Stock Analysis Report
Coherent Corp. (COHR): Free Stock Analysis Report
Lumentum Holdings Inc. (LITE): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).